Overview
Key stats
Fundamentals Sep 9- Open
- $79.75
- 52-wk high
- $82.94
- High
- $80.43
- 52-wk low
- $35.20
- Low
- $77.90
- Prev close
- $80.47
- Mkt cap
- $5.93B
- P/E
- 77.9x
- Volume
- 430.0K
- Fwd P/E
- 61.0x
- Beta
- 0.09
- P/S
- 7.2x
- P/B
- 9.3x
- Profit margin
- +9.6%
- Op margin
- +11.2%
- ROE
- +14.0%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Earnings
Earnings came in 16.7% below what analysts expected.
Earnings per share
$0.32 expected
Reports Oct 27, 2026, in 47 days
EPS expected
$0.28 to $0.37
Revenue expected
8 analysts
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $180.9M | $202.1M | $214.3M | $243.6M |
| Cost of what it sold | $83.6M | $91.1M | $96.4M | $111.6M |
| Gross profit | $97.3M | $111.0M | $117.9M | $132.0M |
| What it spent | ||||
| Research and development | $24.1M | $34.6M | $27.5M | $40.9M |
| Sales and admin | $49.1M | $56.8M | $61.2M | $63.9M |
| Total operating expenses | $73.2M | $91.3M | $88.6M | $104.8M |
| What was left | ||||
| Operating profit | $24.0M | $19.8M | $29.3M | $27.2M |
| Profit before tax | $27.2M | $23.3M | $32.7M | $31.1M |
| Tax | $8.7M | $9.1M | $10.1M | $5.7M |
| Net profit | $18.4M | $14.2M | $22.6M | $25.4M |
| EBITDA | $27.5M | $23.7M | $33.1M | $27.7M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
80 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Headlands Technologies LLC Purchases Shares of 18,161 Kiniksa Pharmaceuticals International, plc $KNSA
Leans bullishSep 1Kiniksa Pharmaceuticals International, plc (NASDAQ:KNSA) Given Average Recommendation of "Moderate Buy" by Brokerages
BullishAug 31
Macro
10 macro signals shaping KNSA right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results